Liqiang Chen

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Molecular Dynamics Simulations

Anti Inflammatory

Single Molecule

Top Venues

Molecules (Basel, Switzerland)

Journal of medicinal chemistry

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Teng Ai, Daniel J Wilson, Liqiang Chen
5-((3-Amidobenzyl)oxy)nicotinamides as SIRT2 Inhibitors: A Study of Constrained Analogs. Molecules (Basel, Switzerland) 28 (22) (2023)
Eunkyung Jung, Ruben Soto-Acosta, Robert J Geraghty, Liqiang Chen
Zika Virus Inhibitors Based on a 1,3-Disubstituted 1 H -Pyrazolo[3,4- d ]pyrimidine-amine Scaffold. Molecules (Basel, Switzerland) 27 (18) (2022)
Eunkyung Jung, Ruben Soto-Acosta, Jiashu Xie, Daniel J Wilson, Christine D Dreis, Ryuichi Majima, Tiffany C Edwards, Robert J Geraghty, Liqiang Chen
Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase. ACS medicinal chemistry letters 13 (9) (2022)
Ruben Soto-Acosta, Eunkyung Jung, Li Qiu, Daniel J Wilson, Robert J Geraghty, Liqiang Chen
4,7-Disubstituted 7H-Pyrrolo[2,3-d]pyrimidines and Their Analogs as Antiviral Agents against Zika Virus. Molecules (Basel, Switzerland) 26 (13) (2021)
Rui Ding, Ting Zhang, Daniel J Wilson, Jiashu Xie, Jessica Williams, Yue Xu, Yihong Ye, Liqiang Chen
Discovery of Irreversible p97 Inhibitors. Journal of medicinal chemistry 62 (5) (2019)